Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Aldrich

Showing results (391-400 of 552) with videos related to

Pageof 56
Sort By:
Science Translational Medicine|April 27, 2018
Targeting protein biotinylation enhances tuberculosis chemotherapyDivya Tiwari, Sae Woong Park, Maram M Essawy, et al.
Medrxiv : the Preprint Server for Health Sciences|July 1, 2024
Germline prediction of immune checkpoint inhibitor discontinuation for immune-related adverse eventsPooja Middha, Rohit Thummalapalli, Zoe Quandt, et al.
Journal for Immunotherapy of Cancer|March 28, 2025
Germline prediction of immune checkpoint inhibitor discontinuation for immune-related adverse eventsPooja Middha, Rohit Thummalapalli, Zoe Quandt, et al.
Molecular Cell|November 21, 2015
Polyketide Quinones Are Alternate Intermediate Electron Carriers during Mycobacterial Respiration in Oxygen-Deficient NichesAmitesh Anand, Priyanka Verma, Anil Kumar Singh, et al.
American Journal of Respiratory and Critical Care Medicine|October 1, 2020
Addressing Disparities in Lung Cancer Screening Eligibility and Healthcare Access. An Official American Thoracic Society StatementM Patricia Rivera, Hormuzd A Katki, Nichole T Tanner, et al.
Journal of Medicinal Chemistry|January 17, 2025
Metabolically Stable Adenylation Inhibitors of Biotin Protein Ligase as Antibacterial AgentsQiang Liu, Curtis A Engelhart, Joshua B Wallach, et al.
Biorxiv : the Preprint Server for Biology|October 3, 2025
Structure-Guided Development of a Potent BioA Inhibitor Validates Biotin Synthesis Inhibition as a Therapeutic Strategy for TuberculosisQiang Liu, Joshua B Wallach, Yahani P Jayasinghe, et al.
The Journal of Biological Chemistry|November 18, 2021
Cardiac ryanodine receptor N-terminal region biosensors identify novel inhibitors via FRET-based high-throughput screeningJingyan Zhang, Daniel P Singh, Christopher Y Ko, et al.
The Annals of Thoracic Surgery|March 1, 2014
Accuracy of fluorodeoxyglucose-positron emission tomography within the clinical practice of the American College of Surgeons Oncology Group Z4031 trial to diagnose clinical stage I non-small cell lung cancerEric L Grogan, Stephen A Deppen, Karla V Ballman, et al.
ACS Infectious Diseases|January 18, 2019
Investigation of ( S)-(-)-Acidomycin: A Selective Antimycobacterial Natural Product That Inhibits Biotin SynthaseMatthew R Bockman, Curtis A Engelhart, Julia D Cramer, et al.
Pageof 56

Showing results (391-400 of 552) with videos related to

Sort By:
Pageof 56
Science Translational Medicine|April 27, 2018
Targeting protein biotinylation enhances tuberculosis chemotherapyDivya Tiwari, Sae Woong Park, Maram M Essawy, et al.
Medrxiv : the Preprint Server for Health Sciences|July 1, 2024
Germline prediction of immune checkpoint inhibitor discontinuation for immune-related adverse eventsPooja Middha, Rohit Thummalapalli, Zoe Quandt, et al.
Journal for Immunotherapy of Cancer|March 28, 2025
Germline prediction of immune checkpoint inhibitor discontinuation for immune-related adverse eventsPooja Middha, Rohit Thummalapalli, Zoe Quandt, et al.
Molecular Cell|November 21, 2015
Polyketide Quinones Are Alternate Intermediate Electron Carriers during Mycobacterial Respiration in Oxygen-Deficient NichesAmitesh Anand, Priyanka Verma, Anil Kumar Singh, et al.
American Journal of Respiratory and Critical Care Medicine|October 1, 2020
Addressing Disparities in Lung Cancer Screening Eligibility and Healthcare Access. An Official American Thoracic Society StatementM Patricia Rivera, Hormuzd A Katki, Nichole T Tanner, et al.
Journal of Medicinal Chemistry|January 17, 2025
Metabolically Stable Adenylation Inhibitors of Biotin Protein Ligase as Antibacterial AgentsQiang Liu, Curtis A Engelhart, Joshua B Wallach, et al.
Biorxiv : the Preprint Server for Biology|October 3, 2025
Structure-Guided Development of a Potent BioA Inhibitor Validates Biotin Synthesis Inhibition as a Therapeutic Strategy for TuberculosisQiang Liu, Joshua B Wallach, Yahani P Jayasinghe, et al.
The Journal of Biological Chemistry|November 18, 2021
Cardiac ryanodine receptor N-terminal region biosensors identify novel inhibitors via FRET-based high-throughput screeningJingyan Zhang, Daniel P Singh, Christopher Y Ko, et al.
The Annals of Thoracic Surgery|March 1, 2014
Accuracy of fluorodeoxyglucose-positron emission tomography within the clinical practice of the American College of Surgeons Oncology Group Z4031 trial to diagnose clinical stage I non-small cell lung cancerEric L Grogan, Stephen A Deppen, Karla V Ballman, et al.
ACS Infectious Diseases|January 18, 2019
Investigation of ( S)-(-)-Acidomycin: A Selective Antimycobacterial Natural Product That Inhibits Biotin SynthaseMatthew R Bockman, Curtis A Engelhart, Julia D Cramer, et al.
Pageof 56